Reports Q1 revenue $819.799M, consensus $796.63M. “The opening months of 2026 have set the stage for what will be a defining year for AdaptHealth (AHCO),” said Suzanne Foster, Chief Executive Officer. “We completed the largest de novo expansion in the history of the home medical equipment industry, delivering revenue well ahead of our first quarter guidance, with broad-based organic growth across all four segments. Although we incurred elevated labor costs to execute the transition responsibly, we are already working to optimize the business for our newly attained scale.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO:
- AdaptHealth price target raised to $11 from $9.50 at Jefferies
- AdaptHealth price target raised to $14 from $13 at Truist
- AdaptHealth Boosts Liquidity With New $1.1 Billion Credit Facility
- AdaptHealth announces refinancing of senior secured credit facility
- AdaptHealth rallies after CEO buys $4.4M of shares
